Virtus LifeSci Biotech Cl... (BBC)

NYSEArca: BBC · Real-Time Price · USD

54.23

+0.42 (0.78%)

At close: Aug 19, 2026, 3:59 PM

0.78% (1D)

Bid	55.95
Market Cap	n/a
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Beta	n/a
EPS (ttm)	n/a
PE Ratio (ttm)	n/a
Forward PE	n/a
P/B (ttm)	n/a
P/S (ttm)	n/a
Earnings Date	n/a

Ask	87.42
Volume	48,337
Avg. Volume (20D)	22,911
Open	54.83
Previous Close	53.81
Day's Range	54.80 - 56.02
52-Week Range	22.12 - 56.18
Analyst	n/a
Price Target	n/a
Dividends	n/a
Ex-Dividend Date	n/a

About BBC

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval....

[Read more]

Industry n/a

Sector n/a

IPO Date Dec 17, 2014

Employees n/a

Stock Exchange NYSEArca

Ticker Symbol BBC

Full Company Profile

Financial Performance

In undefined, Virtus LifeSci Biotech Clinical Trials ETF's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.

Financial Statements

News

3 weeks ago · MarketBeat

Innovative ETF Strategies That Are Paying Off This Summer

Amid record ETF inflows, niche funds like BBC, LATR, and FMED offer targeted exposure to biotech trials, buy-now-pay-later firms, and disruptive medicine, with notable recent returns.